Hillstream BioPharma Inc.

NASDAQ: HILS · Real-Time Price · USD
0.24
0.02 (7.00%)
At close: Sep 22, 2023, 9:59 PM

Hillstream BioPharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-9.32M -8.47M -2.21M
Depreciation & Amortization
n/a 1.57B 666.57K
Stock-Based Compensation
831.86K 800.7K 1.24M
Other Working Capital
45.93K -427.94K 196.92K
Other Non-Cash Items
1.23M -1.57B -1.17M
Deferred Income Tax
n/a n/a -666.57K
Change in Working Capital
-45.93K -569.11K 1.05M
Operating Cash Flow
-7.3M -6.56M -1.09M
Capital Expenditures
n/a n/a n/a
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a
Investing Cash Flow
n/a n/a n/a
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a -69.97K n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
11.72M 13.06M 898.75K
Financial Cash Flow
11.72M 13.06M 898.75K
Net Cash Flow
4.42M 6.51M -187.5K
Free Cash Flow
-7.3M -6.56M -1.09M